Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
5.36
+0.09 (1.71%)
Nov 20, 2024, 4:00 PM EST - Market closed
Voyager Therapeutics Employees
Voyager Therapeutics had 162 employees as of December 31, 2023. The number of employees increased by 37 or 29.60% compared to the previous year.
Employees
162
Change (1Y)
37
Growth (1Y)
29.60%
Revenue / Employee
$1,011,012
Profits / Employee
$159,753
Market Cap
292.79M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Accolade | 2,400 |
OraSure Technologies | 638 |
uniQure | 480 |
Vanda Pharmaceuticals | 203 |
Nautilus Biotechnology | 167 |
iTeos Therapeutics | 157 |
C4 Therapeutics | 145 |
Atai Life Sciences | 83 |
VYGR News
- 8 days ago - Voyager Therapeutics, Inc. (VYGR) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Voyager Reports Third Quarter 2024 Financial and Operating Results - GlobeNewsWire
- 15 days ago - Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences - GlobeNewsWire
- 16 days ago - Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast - GlobeNewsWire
- 2 months ago - Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - Voyager: Anti-Tau Antibody Differentiation For AD Treatment Could Boost Prospects - Seeking Alpha
- 3 months ago - Voyager Therapeutics, Inc. (VYGR) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Voyager Therapeutics to Present at Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase - GlobeNewsWire